Postoperative Sleep Disturbances

2

Review clinical trials related to Postoperative Sleep Disturbances. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effectiveness of Perioperative Percutaneous Acupuncture on Postoperative Sleep Disturbances and Chronic Pain in Patients Undergoing Video-Assisted Thoracoscopic Lung Cancer Resection: A Prospective, Randomized, Single-Blind, Superiority Controlled Trial

This study evaluates whether acupuncture at specific body points before and after surgery can improve sleep quality and reduce long-term postoperative pain in patients undergoing video-assisted thoracoscopic lung cancer resection. Eligible adult patients will be randomly assigned to receive either true acupuncture or sham (placebo) acupuncture in addition to standard care. Chronic pain will be assessed during hospital stay and up to 6 months after surgery.

Participants needed: 316
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineUpdated: Jun 23, 2026Locations: 2
Eligibility criteria

Patients aged 18-75 years scheduled for elective video-assisted thoracoscopic su... [+5]

Critical preoperative condition or inability to cooperate. [+11]

Status: Recruiting

Dexmedetomidine-Esketamine Combination and Sleep Disturbances After Major Noncardiac Surgery

Sleep disturbances are common early after major surgery, and are associated with delayed recovery. A previous study showed that dexmedetomidine-esketamine combination as a supplement to patient-controlled intravenous analgesia improved postoperative analgesia and subjective sleep quality in patients after scoliosis correction surgery. The purpose of this trial is to test the hypothesis that dexmedetomidine-esketamine combination used as a supplement during general anesthesia and postoperative intravenous analgesia may reduce sleep disturbances in adult after major noncardiac surgery.

Participants needed: 476
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Peking University First HospitalUpdated: Mar 19, 2025Locations: 1
Eligibility criteria

Aged ≥18 years. [+2]

Emergency surgery, transurethral surgery, organ transplantation. [+10]